Enedra Therapeutics
PrivateLast Round
VC Round
May 6, 2025
Company Overview
Enedra Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in May 2025.
Enedra Therapeutics is a biotechnology company developing next-generation precision therapies for advanced, genetically heterogeneous cancers. The company leverages its proprietary AI-driven CASPAROV platform to discover novel drug targets and patient-specific biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enedra Therapeutics Comparables
Compare Enedra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mosaic Therapeutics | 86% | |
| Tailor Bio | 84% | |
| Evariste | 80% |
For institutional investors. Book with your work email.
Enedra Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Enedra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Seed, VC Round |
| o2h ventures | VC Round |
| Centre for Drug Design and Discovery | VC Round |
| Cancer Research Horizons | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2025
Raised VC Round led by o2h ventures and Centre for Drug Design and Discovery.
For institutional investors. Book with your work email.
Enedra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enedra Therapeutics's valuation, stock price, and market status.
Is Enedra Therapeutics a public or private company?
Enedra Therapeutics is a private company.
What is the current stock price of Enedra Therapeutics?
Enedra Therapeutics is a private company, so its shares have no public market price. Caplight tracks Enedra Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enedra Therapeutics worth (valuation)?
Valuation information for Enedra Therapeutics is not publicly available.
Can I buy Enedra Therapeutics stock?
Enedra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enedra Therapeutics's last funding round?
Enedra Therapeutics's most recent funding round was VC Round on May 6, 2025.
Who are the main investors in Enedra Therapeutics?
Key investors in Enedra Therapeutics include o2h ventures, Centre for Drug Design and Discovery.
Will Enedra Therapeutics IPO soon?
No public IPO plans have been announced for Enedra Therapeutics.
How can I track Enedra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Enedra Therapeutics's shares on secondary markets.